Literature DB >> 18206987

Cholesterol-deprivation increases mono-unsaturated very long-chain fatty acids in skin fibroblasts from patients with X-linked adrenoleukodystrophy.

M Engelen1, R Ofman, P A W Mooijer, B T Poll-The, R J A Wanders, S Kemp.   

Abstract

X-linked adrenoleukodystrophy (X-ALD) is the most common peroxisomal disorder and is characterized by a striking and unpredictable variation in phenotypic expression. It ranges from a rapidly progressive and fatal cerebral demyelinating disease in childhood (CCALD), to the milder slowly progressive form in adulthood (AMN). X-ALD is caused by mutations in the ABCD1 gene that encodes a peroxisomal membrane located ABC half-transporter named ALDP. Mutations in ALDP result in reduced beta-oxidation of very long-chain fatty acids (VLCFA, >22 carbon atoms) in peroxisomes and elevated levels of VLCFA in plasma and tissues. Previously, it has been shown that culturing skin fibroblasts from X-ALD patients in lipoprotein-deficient medium results in reduced VLCFA levels and increased expression of the functionally redundant ALD-related protein (ALDRP). The aim of this study was to further resolve the interaction between cholesterol and VLCFA metabolism in X-ALD. Our data show that the reduction in 26:0 in X-ALD fibroblasts grown in lipoprotein-deficient culture medium (free of cholesterol) is offset by a significant increase in both the level and synthesis of 26:1. We also demonstrate that cholesterol-deprivation results in increased expression of stearoyl-CoA-desaturase (SCD) and increased desaturation of 18:0 to 18:1. Finally, there was no increase in [1-(14)C]-26:0 beta-oxidation. Taken together, we conclude that cholesterol-deprivation reduces saturated VLCFA, but increases mono-unsaturated VLCFA. These data may have implications for treatment of X-ALD patients with lovastatin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18206987     DOI: 10.1016/j.bbalip.2007.12.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Betulinic acid induces a novel cell death pathway that depends on cardiolipin modification.

Authors:  L Potze; S Di Franco; C Grandela; M L Pras-Raves; D I Picavet; H A van Veen; H van Lenthe; F B Mullauer; N N van der Wel; A Luyf; A H C van Kampen; S Kemp; V Everts; J H Kessler; F M Vaz; J P Medema
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

2.  Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy.

Authors:  Quentin Raas; Malu-Clair van de Beek; Sonja Forss-Petter; Inge Me Dijkstra; Abigail Deschiffart; Briana C Freshner; Tamara J Stevenson; Yorrick Rj Jaspers; Liselotte Nagtzaam; Ronald Ja Wanders; Michel van Weeghel; Joo-Yeon Engelen-Lee; Marc Engelen; Florian Eichler; Johannes Berger; Joshua L Bonkowsky; Stephan Kemp
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

3.  Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid--a case report.

Authors:  Gisella Terre'Blanche; Mietha M van der Walt; Jacobus J Bergh; Lodewyk J Mienie
Journal:  Lipids Health Dis       Date:  2011-08-26       Impact factor: 3.876

4.  The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy.

Authors:  Rob Ofman; Inge M E Dijkstra; Carlo W T van Roermund; Nena Burger; Marjolein Turkenburg; Arno van Cruchten; Catherine E van Engen; Ronald J A Wanders; Stephan Kemp
Journal:  EMBO Mol Med       Date:  2010-03       Impact factor: 12.137

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.